Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone

被引：48
|
作者：
Leung, Nelson [1 ,2 ]
Thome, Stephan D. [3 ]
Dispenzieri, Angela [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[3] Mayo Clin, Div Med Oncol, Rochester, MN USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 03期
关键词：
MONOCLONAL GAMMOPATHY; AL AMYLOIDOSIS; THERAPY; TRANSLOCATION; SURVIVAL; T(11/14); MYELOMA;
D O I：
10.3324/haematol.2017.183749
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E135 / E137
页数：3
相关论文
共 50 条
  • [1] Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
    Premkumar, Vikram
    Comenzo, Raymond
    Lentzsch, Suzanne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : 686 - 688
  • [2] A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosis
    Liu, Baojian
    Wang, Yan
    Ning, Xiaoxuan
    Bai, Ming
    Wang, Di
    Zhao, Jin
    Zhou, Meilan
    Sun, Shiren
    CURRENT PROBLEMS IN CANCER, 2021, 45 (02)
  • [3] Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis
    Kastritis, Efstathios
    Leleu, Xavier
    Arnulf, Bertrand
    Zamagni, Elena
    Cibeira, Maria Teresa
    Kwok, Fiona
    Mollee, Peter
    Hajek, Roman
    Moreau, Philippe
    Jaccard, Arnaud
    Schoenland, Stefan O.
    Filshie, Robin
    Nicolas-Virelizier, Emmanuelle
    Augustson, Bradley
    Mateos, Maria-Victoria
    Wechalekar, Ashutosh
    Hachulla, Eric
    Milani, Paolo
    Dimopoulos, Meletios A.
    Fermand, Jean-Paul
    Foli, Andrea
    Gavriatopoulou, Maria
    Klersy, Catherine
    Palumbo, Antonio
    Sonneveld, Pieter
    Johnsen, Hans Erik
    Merlini, Giampaolo
    Palladini, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3252 - 3260
  • [4] Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Fotiou, Despina
    Kanellias, Nikolaos
    Migkou, Magdalini
    Tselegkidi, Maria Irini
    Marinaki, Smaragdi
    Psimenou, Erasmia
    Ntanasis-Stathopoulos, Ioannis
    Gakiopoulou, Harikleia
    Papanota, Aristea-Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E320 - E321
  • [5] Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
    Porcari, Aldostefano
    Pagura, Linda
    Rossi, Maddalena
    Porrazzo, Marika
    Dore, Franca
    Bussani, Rossana
    Merlo, Marco
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 6 (04)
  • [6] Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis
    Mikhael, Joseph R.
    Schuster, Steven R.
    Jimenez-Zepeda, Victor H.
    Bello, Nancy
    Spong, Jacy
    Reeder, Craig B.
    Stewart, A. Keith
    Bergsagel, P. Leif
    Fonseca, Rafael
    BLOOD, 2012, 119 (19) : 4391 - 4394
  • [7] Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
    Kastritis, E.
    Anagnostopoulos, A.
    Roussou, M.
    Toumanidis, S.
    Pamboukas, C.
    Tassidou, A.
    Xilouri, I.
    Delibasi, S.
    Psimenou, E.
    Mellou, S.
    Terpos, E.
    Nanas, J.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 200 - 200
  • [8] Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
    Kastritis, Efstathios
    Anagnostopoulos, Athanasios
    Roussou, Maria
    Toumanidis, Savvas
    Pamboukas, Constantinos
    Migkou, Magdalini
    Tassidou, Anna
    Xilouri, Irini
    Delibasi, Sossana
    Psimenou, Erasmia
    Mellou, Sofia
    Terpos, Evangelos
    Nanas, John
    Dimopoulos, Meletios A.
    HAEMATOLOGICA, 2007, 92 (10) : 1351 - 1358
  • [9] Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
    Kastritis, Efstathios
    Wechalekar, Ashutosh D.
    Dimopoulos, Meletios A.
    Merlini, Giampaolo
    Hawkins, Philip N.
    Perfetti, Vittorio
    Gillmore, Julian D.
    Palladini, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 1031 - 1037
  • [10] Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis
    Le Bras, Fabien
    Molinier-Frenkel, Valerie
    Guellich, Aziz
    Dupuis, Jehan
    Belhadj, Karim
    Guendouz, Soulef
    Ayad, Karima
    Colombat, Magali
    Benhaiem, Nicole
    Tissot, Claire Marie
    Hulin, Anne
    Jaccard, Arnaud
    Damy, Thibaud
    EUROPEAN JOURNAL OF CANCER, 2017, 76 : 183 - 187
12345